Abdulrahman Nasiri: Bone Marrow Biopsy Safety on Anticoagulation
Abdulrahman Nasiri, Hematologist, Assistant Professor at Imam Muhammad ibn Saud Islamic University, posted on LinkedIn:
”Honored to be participating in the MENA Hematology Congress 2025 held in Al-Madinah, where I presented our paper titled:
Safety of Bone Marrow Biopsy in Patients Receiving Anticoagulation Therapy
A Systematic Review and Meta-Analysis
This work reviewed more than 65,000 bone marrow biopsy procedures, including over 1,000 anticoagulated patients. The analysis showed that bone marrow biopsy maintains an excellent safety profile, even in patients on anticoagulation, and highlighted the patient-specific factors that truly influence bleeding risk.
Grateful for the opportunity to share this research among distinguished hematologists and researchers across the region.
The congress is still ongoing, and I look forward to the remaining sessions and discussions.
My appreciation to the organizers for a well-executed scientific meeting and to colleagues who enriched the exchange with their insights.”
Stay updated with Hemostasis Today.
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management